Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Pharma discloses some payments to Canadian docs, but critics want more

  • Ed Silverman

By Ed Silverman June 21, 2017

Reprints
Astellas Suspended
APStock

File this under “Half a loaf.”

A long-awaited move by the pharmaceutical industry to offer more transparency into its practices appears to have backfired in Canada, where newly disclosed payments to doctors and hospitals is sparking criticism and calls for mandatory reporting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed Silverman covers the pharmaceutical industry.

Tags

Wary of changes to Medicare Advantage, health insurers put…
Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the…
Researchers pursuing novel treatments for herpes infections and diabetes…
Researchers pursuing novel treatments for herpes infections and diabetes win STAT Madness
Opioid epidemic shares chilling similarities with past drug crises
Opioid epidemic shares chilling similarities with past drug crises
Oscar Health names former Aetna executive as new CEO
Oscar Health names former Aetna executive as new CEO
Pharmalittle: Ohio attorney general accuses PBMs of price fixing;…
Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price…
With new study data, Intra-Cellular could expand use of…
With new study data, Intra-Cellular could expand use of approved mood-disorder treatment

Recommended Stories